Laraway Financial Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$319K Sell
1,512
-314
-17% -$67.6K 0.22% 102
2025
Q4
$375K Hold
1,826
0.24% 90
2025
Q3
$287K Sell
1,826
-5
-0.3% -$772 0.2% 110
2025
Q2
$308K Buy
1,831
+1
+0.1% +$148 0.23% 97
2025
Q1
$252K Hold
1,830
0.2% 104
2024
Q4
$216K Buy
1,830
+1
+0.1% +$117 0.17% 112
2024
Q3
$202K Buy
1,829
+1
+0.1% +$105 0.16% 113
2024
Q2
$180K Hold
1,828
0.15% 109
2024
Q1
$205K Buy
+1,828
New +$197K 0.18% 108

Other funds holding CAH

Laraway Financial Advisors's CAH Position: Q1 2026 in Review

Laraway Financial Advisors reduced its Cardinal Health (CAH) stake by 17% in Q1 2026, selling an estimated $67.6K and leaving 1,512 shares worth $319K. The position accounts for 0.22% of the portfolio, ranked #102.

Laraway Financial Advisors first reported a position in CAH in Q1 2024 and has held it in 9 quarters since. The position peaked at $375K in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Laraway Financial Advisors held 1,512 shares of Cardinal Health worth $319K as of Q1 2026.
  • Laraway Financial Advisors sold 314 Cardinal Health shares in Q1 2026, an estimated $67.6K.
  • Cardinal Health made up 0.22% of Laraway Financial Advisors's portfolio in Q1 2026, its #102 holding.
  • Laraway Financial Advisors first reported a position in Cardinal Health in Q1 2024 and has held it in 9 quarters since.
  • Laraway Financial Advisors's Cardinal Health position peaked at $375K in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Laraway Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.